{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:04:20Z","timestamp":1784106260872,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":110,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R41 HL156602"],"award-info":[{"award-number":["R41 HL156602"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32 DK124191"],"award-info":[{"award-number":["T32 DK124191"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK136328"],"award-info":[{"award-number":["R01 DK136328"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK123704"],"award-info":[{"award-number":["P30 DK123704"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","award":["S10 OD010731"],"award-info":[{"award-number":["S10 OD010731"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM130457"],"award-info":[{"award-number":["P20 GM130457"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30 GM140964"],"award-info":[{"award-number":["P30 GM140964"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jcmgh.2026.101796","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:49:05Z","timestamp":1777600145000},"page":"101796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triazine Thiols Decrease Apolipoprotein B Secretion From Hepatocytes Through Inhibition of Human Carboxylesterase 1"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0337-584X","authenticated-orcid":false,"given":"Josef","family":"Blaszkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Tung","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Martinez-Morant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Dearth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper","family":"van Altena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Paige","family":"Lamprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"Kappler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Bethard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2507-7827","authenticated-orcid":false,"given":"Stephen A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2026.101796_bib1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib2","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmgh.2026.101796_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11886-021-01565-5","article-title":"Familial hypercholesterolemia: global burden and approaches","volume":"23","author":"Tokgozoglu","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jcmgh.2026.101796_bib4","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcmgh.2026.101796_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCULATIONAHA.115.018791","article-title":"Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)","volume":"133","author":"De Ferranti","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcmgh.2026.101796_bib6","first-page":"169","article-title":"Familial Hypercholesterolemia","volume":"33","author":"Bouhairie","year":"2015","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.jcmgh.2026.101796_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmgh.2026.101796_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fphar.2018.00707","article-title":"Familial hypercholesterolemia: new horizons for diagnosis and effective management","volume":"9","author":"Mytilinaiou","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib10","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmgh.2026.101796_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1194\/jlr.R200014-JLR200","article-title":"Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly","volume":"44","author":"Hussain","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcmgh.2026.101796_bib12","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/ATVBAHA.111.241471","article-title":"Intracellular trafficking and secretion of VLDL","volume":"32","author":"Tiwari","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib13","doi-asserted-by":"crossref","first-page":"463S","DOI":"10.1093\/jn\/129.2.463S","article-title":"Assembly of very low density lipoprotein: a two-step process of apolipoprotein B core lipidation","volume":"129","author":"Rustaeus","year":"1999","journal-title":"J Nutr"},{"key":"10.1016\/j.jcmgh.2026.101796_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib15","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacl.2023.03.010","article-title":"Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: a cross-sectional study","volume":"17","author":"de Boer","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2018.12.037","article-title":"Value of measuring lipoprotein(a) during cascade testing for familial hypercholesterolemia","volume":"73","author":"Ellis","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib18","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3389\/fphys.2020.595819","article-title":"PCSK9 inhibition: insights from clinical trials and future prospects","volume":"11","author":"Katzmann","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/10742484221100107","article-title":"A comprehensive review of PCSK9 inhibitors","volume":"27","author":"Coppinger","year":"2022","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jcmgh.2026.101796_bib20","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.113.001292","article-title":"Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia","volume":"129","author":"Rader","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jcmgh.2026.101796_bib21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2026.101796_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for Homozygous Familial Hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmgh.2026.101796_bib23","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s40265-018-1009-0","article-title":"Why biologics and biosimilars remain so expensive: despite two wins for biosimilars, the supreme court\u2019s recent rulings do not solve fundamental barriers to competition","volume":"78","author":"Chen","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jcmgh.2026.101796_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1744-9987.13856","article-title":"Complementary role of evinacumab in combination with lipoprotein apheresis in patients with homozygous familial hypercholesterolemia","volume":"26","author":"Duell","year":"2022","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jcmgh.2026.101796_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-04154-6","article-title":"A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B","volume":"6","author":"Liu","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib26","article-title":"Using human induced pluripotent stem cell-derived hepatocyte-like cells for drug discovery","volume":"2018","author":"Liu","year":"2018","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jcmgh.2026.101796_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1248\/bpb.b14-00679","article-title":"Carboxylesterase 1-mediated drug\u2013drug interactions between clopidogrel and simvastatin","volume":"38","author":"Wang","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jcmgh.2026.101796_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cbi.2016.02.011","article-title":"Carboxylesterases: general detoxifying enzymes","volume":"259","author":"Hatfield","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jcmgh.2026.101796_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/dmd.116.074732","article-title":"Global proteomic analysis of human liver microsomes: rapid characterization and quantification of hepatic drug-metabolizing enzymes","volume":"45","author":"Achour","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jcmgh.2026.101796_bib30","doi-asserted-by":"crossref","first-page":"33218","DOI":"10.1074\/jbc.M706841200","article-title":"Proteomic and lipid characterization of apolipoprotein B-free luminal lipid droplets from mouse liver microsomes: implications for very low density lipoprotein assembly","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101796_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13238-017-0437-z","article-title":"Carboxylesterases in lipid metabolism: from mouse to human","volume":"9","author":"Lian","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.jcmgh.2026.101796_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/srep25747","article-title":"Ces3\/TGH deficiency attenuates steatohepatitis","volume":"6","author":"Lian","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2026.101796_bib33","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/hep.25881","article-title":"Liver specific inactivation of carboxylesterase 3\/triacylglycerol hydrolase decreases blood lipids without causing severe steatosis in mice","volume":"56","author":"Lian","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101796_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-0716-0954-5_15","article-title":"Drug affinity responsive target stability (DARTS) assay to detect interaction between a purified protein and a small molecule","volume":"2213","author":"Huang","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0167-4838(96)00118-5","article-title":"Slow-binding inhibition: the general case","volume":"1298","author":"Sculley","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcmgh.2026.101796_bib36","series-title":"Enzymes a practical introduction to structure, mechanism, and data analysis","author":"Copeland","year":"2000"},{"key":"10.1016\/j.jcmgh.2026.101796_bib37","doi-asserted-by":"crossref","first-page":"W498","DOI":"10.1093\/nar\/gkae406","article-title":"MolModa: accessible and secure molecular docking in a web browser","volume":"52","author":"Kochnev","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcmgh.2026.101796_bib38","article-title":"Comparison of the structure and activity of glycosylated and aglycosylated human carboxylesterase 1","volume":"10","author":"De Souza","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2026.101796_bib39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1359-6446(05)03383-0","article-title":"Mammalian carboxylesterases: from drug targets to protein therapeutics","volume":"10","author":"Redinbo","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jcmgh.2026.101796_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nsb919","article-title":"Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme","volume":"10","author":"Bencharit","year":"2003","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jmb.2006.08.025","article-title":"Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1","volume":"363","author":"Bencharit","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib42","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1021\/bi700246n","article-title":"Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun","volume":"46","author":"Fleming","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jcmgh.2026.101796_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/prot.22154","article-title":"Improving accuracy and efficiency of blind protein-ligand docking by focusing on predicted binding sites","volume":"74","author":"Ghersi","year":"2009","journal-title":"Proteins"},{"key":"10.1016\/j.jcmgh.2026.101796_bib44","doi-asserted-by":"crossref","first-page":"1G.4.1","DOI":"10.1002\/9780470151808.sc01g04s26","article-title":"Differentiation of hepatocytes from pluripotent stem cells","volume":"26","author":"Mallanna","year":"2013","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells","volume":"51","author":"Si-Tayeb","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101796_bib46","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1091\/mbc.e04-03-0224","article-title":"Triacylglycerol hydrolase is localized to the endoplasmic reticulum by an unusual retrieval sequence where it participates in VLDL assembly without utilizing VLDL lipids as substrates","volume":"16","author":"Gilham","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.jcmgh.2026.101796_bib47","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.25961","article-title":"Deficiency of carboxylesterase 1\/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia","volume":"56","author":"Quiroga","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2026.101796_bib48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbalip.2016.03.009","article-title":"Liver-specific expression of carboxylesterase 1g\/esterase-x reduces hepatic steatosis, counteracts dyslipidemia and improves insulin signaling","volume":"1861","author":"Bahitham","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcmgh.2026.101796_bib49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nsb790","article-title":"Structural insights into CPT-11 activation by mammalian carboxylesterases","volume":"9","author":"Bencharit","year":"2002","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jmb.2005.07.016","article-title":"Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil","volume":"352","author":"Fleming","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1194\/jlr.M500344-JLR200","article-title":"Mutation of F417 but not of L418 or L420 in the lipid binding domain decreases the activity of triacylglycerol hydrolase","volume":"47","author":"Alam","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcmgh.2026.101796_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2024.101045","article-title":"Strategy for cysteine-targeting covalent inhibitors screening using in-house database based LC-MS\/MS and drug repurposing","volume":"15","author":"Hu","year":"2025","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.jcmgh.2026.101796_bib53","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.chembiol.2019.09.012","article-title":"Recent advances in selective and irreversible covalent ligand development and validation","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib54","doi-asserted-by":"crossref","first-page":"7728","DOI":"10.3390\/molecules27227728","article-title":"Covalent warheads targeting cysteine residue: the promising approach in drug development","volume":"27","author":"Huang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jcmgh.2026.101796_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.antiviral.2017.12.015","article-title":"Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes","volume":"150","author":"Lin","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcmgh.2026.101796_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1764393","article-title":"FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication","volume":"39","author":"Lobo-Galo","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jcmgh.2026.101796_bib57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/dmd.119.089680","article-title":"Carboxylesterase 1 and precision pharmacotherapy: pharmacogenetics and nongenetic regulators","volume":"48","author":"Her","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jcmgh.2026.101796_bib58","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ajhg.2008.04.015","article-title":"Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis","volume":"82","author":"Zhu","year":"2008","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcmgh.2026.101796_bib59","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.163624","article-title":"Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy","volume":"8","author":"Li","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcmgh.2026.101796_bib60","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1073\/pnas.0707460104","article-title":"Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control","volume":"105","author":"Pan","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2026.101796_bib61","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.M008885200","article-title":"The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways","volume":"276","author":"Fisher","year":"2001","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"10.1016\/j.jcmgh.2026.101796_bib62","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1194\/jlr.R800090-JLR200","article-title":"The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism","volume":"50 Suppl","author":"Ginsberg","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcmgh.2026.101796_bib63","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1172\/JCI63563","article-title":"Hepatic sortilin regulates both apolipoprotein B secretion and LDL catabolism","volume":"122","author":"Strong","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcmgh.2026.101796_bib64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1074\/jbc.M116.762005","article-title":"Sortilin 1 modulates hepatic cholesterol lipotoxicity in mice via functional interaction with liver carboxylesterase 1","volume":"292","author":"Li","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcmgh.2026.101796_bib65","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/15548627.2024.2435234","article-title":"Impaired chaperone-mediated autophagy leads to abnormal SORT1 (sortilin 1) turnover and CES1-dependent triglyceride hydrolysis","volume":"21","author":"Choi","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.jcmgh.2026.101796_bib66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-213X-10-81","article-title":"Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors","volume":"10","author":"Si-Tayeb","year":"2010","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-213X-10-60","article-title":"Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum","volume":"10","author":"Nagaoka","year":"2010","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib68","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nmeth902","article-title":"Feeder-independent culture of human embryonic stem cells","volume":"3","author":"Ludwig","year":"2006","journal-title":"Nat Methods"},{"key":"10.1016\/j.jcmgh.2026.101796_bib69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nbt1177","article-title":"Derivation of human embryonic stem cells in defined conditions","volume":"24","author":"Ludwig","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcmgh.2026.101796_bib70","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acschemneuro.7b00111","article-title":"Biotinylated bioluminescent probe for long lasting targeted in vivo imaging of xenografted brain tumors in mice","volume":"9","author":"Jiang","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jcmgh.2026.101796_bib71","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/nprot.2016.136","article-title":"The MaxQuant computational platform for mass spectrometry-based shotgun proteomics","volume":"11","author":"Tyanova","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jcmgh.2026.101796_bib72","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.jcmgh.2026.101796_bib73","first-page":"1084","article-title":"GATA6 is essential for endoderm formation from human pluripotent stem cells","volume":"6","author":"Fisher","year":"2017","journal-title":"Biol Open"},{"key":"10.1016\/j.jcmgh.2026.101796_bib74","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat Protoc"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X26000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:13:48Z","timestamp":1784103228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X26000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2352345X26000743"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101796","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triazine Thiols Decrease Apolipoprotein B Secretion From Hepatocytes Through Inhibition of Human Carboxylesterase 1","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2026.101796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101796"}}